Introduction: Analysis of sample allows estimating reserves of the clinical control of a cancer, for example - research of five-year survival depending from a stage of the tumor growth motivates development of practice of early diagnostics (of screening). Aim: To estimate the probability of the five-year survival of patients with MC in sample them from clinic stream of TCB of RSSPMCO&R depending on a stage of tumor growth during 2017-2022 - in the conditions of absence of the developed practice of MC screening. Material and methods: A casual selection with formatting of the sample from a stream of patients with MC who were treated in period from 01.07.2017 to 31.12.2022; an estimation of their probability of five year survival. Control date (CD) supervision - 01.04.2023 Results: The women who were taken on the dispensary account with diagnosis of MC for the first time and had been treating in clinic of TCB of RSSPMCO&R constituted about three quarters (76,0%) of the stream of patients which was formed by this clinic. The basic fraction of this stream (45,4 %) was constituted by patients with II stage of MС. The fractions of patients with III-IV stages constituted accordingly 21,8%, 14,9% and these were above statistically (p<0,05) than fraction of patients with 0-I stages (9,1%). The fraction of patients without detected stage of MC (8,9%) was statistically identical to fraction of patients with 0-I stages. During first three years after the beginning of special treatment the survival rate at patients of sample was above (p<0,05) than the same rate at the population level (79,5% (CI95%=77,9÷81,0)). Five-year survival of patients in clinical sample constituted 82,1% (CI95%=78,6÷85,6), and this was statistically above (p>0.05) than same coefficient at population level. At stages 0-I, II, III and IV of MC these coefficients of survival were accordingly 93,0, 87,5, 77,7 and 65,5%, and at patients without detected stage of MC - 78,4%. Conclusion: The five-year survival of patients with 0-I-II-nd stages of MC in clinical sample is statistically equal to survival rate on the population level in socio-economically developed countries of the world. The five-year survival at population level in Tashkent city is significantly limited by a high fraction of patients with III-IV-th stages of MC and fraction of patients without detected stage of MC. This is related with absence of the developed practice of screening in a city.
| Mualliflar | DJURAEV Mirjalol Dehkanovich, RIZAEV Jasur Alimdjanovich, DJURAEV Farrukh Mirjalolovich |
|---|---|
| Jurnal | Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali |
| Nashr sanasi | 2025-09-08 |
| Jild | 10 |
| Son | 3/2 |
| Til | Rus |
рак молочной железы, специальное лечение, выживаемость, mammary cancer; stages of cancer; special treatment; survival rate, sut bezi saratoni, maxsus davolash, tirik qolish
This review article presents current perspectives on the morphological spectrum of primary adrenal tumors, with a focus on differential diagnosis, updated classification systems, and immunohistochemical and molecular…
Introduction: Efficiency of the control of a mammary cancer (МC) is expressed by level of the early diagnostics and the probability of survival of patients on population level. Aim: The efficiency estimation of…
This review article examines the morphological features of desmoid tumors in children and their relevance in predicting clinical outcomes. A correlation has been established between cellularity, Ki-67 proliferation…
The aim of the study: To analyze the molecular-biological characteristics of primary and secondary tumors in patients with breast cancer (BC). Material and methods: A retrospective analysis of data from 133 patients…
This article provides a modern position on the review of chemotherapy for malignant tumors. Theoretical and practical foundations of the mechanism of action of chemotherapy drugs on normal and tumor cells. Indication…
Today, despite the rapid development of vascular surgery, one of its poorly studied sections is the problem of aneurysmal changes in peripheral vessels. Disorders of internal cerebral circulation and thrombosis caused…
This review article analyzes the morphological and immunohistochemical criteria of aggressiveness in phyllodes tumors of the breast. Key prognostic parameters-including cellular atypia, mitotic activity, stromal…
Chronic cerebral ischemia is a progressively developing impairment of cerebral blood circulation that leads to diffuse or small focal damage to brain tissue. This condition is accompanied by characteristic neurological…
Objective: To analyze lymphocyte subpopulation dynamics and prognostic value in 127 metastatic breast cancer patients with liver involvement undergoing chemoimmunotherapy (2016–2022) at the Samarkand Oncology…
The aim of this study was to quantitatively assess motor deficits in patients with different clinical forms of neurological disorders using the MRC muscle strength scale. Data from 80 patients were analyzed, including…
Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar